Biological treatment for degenerative disc disease: Implications for the field of physical medicine and rehabilitation

American Journal of Physical Medicine and Rehabilitation

Volumn 87, Issue 9, 2008, Pages 694-702

  Zhang, Yejia ^a   An, Howard S ^b   Tannoury, Chadi ^a   Thonar, Eugene J M A ^b,c   Freedman, Mitchell K ^a   Anderson, D Greg ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

Biological therapy; Degenerative disc disease; Discogenic back pain; Intervertebral disc; Rehabilitation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 5; GROWTH DIFFERENTIATION FACTOR 5; RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; RECOMBINANT OSTEOGENIC PROTEIN 1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; BONE MORPHOGENETIC PROTEIN;

BACKACHE; BIOLOGICAL THERAPY; CELL THERAPY; DISEASE SEVERITY; DISKOGRAPHY; FLUOROSCOPY; GENE TRANSFER; HUMAN; INTERVERTEBRAL DISK DEGENERATION; PATHOGENESIS; PHYSICAL MEDICINE; REVIEW; SKILL; TISSUE ENGINEERING; ANIMAL; AUTOTRANSPLANTATION; CARTILAGE CELL; CELL TRANSPLANTATION; CYTOLOGY; GENE VECTOR; HISTOLOGY; INTERVERTEBRAL DISK; MESENCHYMAL STEM CELL TRANSPLANTATION; SPINE DISEASE; TRANSPLANTATION;

ANIMALS; BACK PAIN; BONE MORPHOGENETIC PROTEINS; CELL TRANSPLANTATION; CHONDROCYTES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERVERTEBRAL DISK; MESENCHYMAL STEM CELL TRANSPLANTATION; SPINAL DISEASES; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS;

EID: 52449120123     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31817c1945     Document Type: Review

References (105)

1. Woolf AD, Pfleger B: Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56
2. Andersson GB: Epidemiological features of chronic lowback pain. Lancet 1999;354:581-5
3. Yelin E: Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl 2003;68:8-11
4. Borg-Stein J, Wilkins A: Soft tissue determinants of low back pain. Curr Pain Headache Rep 2006;10:339-44
5. Dreyer SJ, Dreyfuss PH: Low back pain and the zygapophysiat (facet) joints. Arch Phys Med Rehabil 1996;77:290-300
6. Schwarzer AC, Aprill CN, Bogduk N: The sacroiliac joint in chronic low back pain. Spine 1995;20:31-7
7. Waddell G: Low back pain: a twentieth century health care enigma. Spine 1996;21:2820-5
8. Boden SD, Davis DO, Dina TS, et al: Abnormal magneticresonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990;72:403-8
9. Boden SD, McCowin PR, Davis DO, et al: Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990;72:1178-84
10. Schwarzer AC, Aprill CN, Derby R, et al: The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine 1994;19:801-6
11. Freemont TJ, LeMaitre C, Watkins A, et al: Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies. Expert Rev Mol Med 2001;2001:1-10
12. Slade SC, Keating JL: Unloaded movement facilitation exercise compared to no exercise or alternative therapy on outcomes for people with nonspecific chronic low back pain: a systematic review. J Manipulative Physiol Ther 2007;30:301-11
13. Andersson GB, Mekhail NA, Block JE: Treatment of intractable discogenic low back pain. A systematic review of spinal fusion and intradiscal electrothermal therapy (IDET). Pain Physician 2006;9:237-48
14. Boswell MV, Colson JD, Sehgal N, et al: A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician 2007;10:229-53
15. Lee CK: Accelerated degeneration of the segment adjacent to a lumbar fusion. Spine 1988;13:375-7
16. Anderson DG, Yoon T, Shen F: Summary statement: biologic repair or regeneration of the intervertebral disc. Spine J 2005;5:304S
17. Buckwalter JAMVC, Boden SD, Eyre DR, Weidenbaum M: Intervertebral disk structure, composition, and mechanical function, in Orthopaedic Basic Science-Biology and Biomechanics of the Musculoskelettal System Rosemont, American Academy of Orthopaedic Surgeons, 2000
18. Urban JP, Holm S, Maroudas A: Nutrition of the intervertebral disc: effect of fluid flow on solute transport. Clin Orthop Relat Res 1982:296-302
19. Stairmand JW, Holm S, Urban JP: Factors influencing oxygen concentration gradients in the intervertebral disc. A theoretical analysis. Spine 1991;16:444-9
20. Holm S, Maroudas A, Urban JP, et al: Nutrition of the intervertebral disc: solute transport and metabolism. Connect Tissue Res 1981;8:101-19
21. Bogduk N, Tynan W, Wilson AS: The nerve supply to the human lumbar intervertebral discs. J Anal 1981;132:39-56
22. Palmgren T. Gronblad M, Virri J, et al: An immunohisto-chemical study of nerve structures in the anulus fibrosus of human normal lumbar intervertebral discs. Spine 1999;24:2075-9
23. Kojima Y, Maeda T, Arai R, et al: Nerve supply to the posterior longitudinal ligament and the intervertebral disc of the rat vertebral column as studied by acetylcholinesterase histochemistry. II. Regional differences in the distribution of the nerve fibres and their origins. J Anat 1990;169:247-55
24. Mooney V: Where is the lumbar pain coming from? Ann Med 1989;21:373-9
25. Adams MA, McNally DS, Dolan P: 'Stress' distributions inside intervertebral discs. The effects of age and degeneration. J Bone Joint Surg Br 1996;78:965-72
26. Fagan A, Moore R, Vernon Roberts B, et al: ISSLS prize winner: the innervation of the intervertebral disc: a quantitative analysis. Spine 2003;28:2570-6
27. Melrose J, Roberts S, Smith S, et al: Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine 2002;27:1278-85
28. Zhang Y, Kerns JM, Anderson DG, et al: Sensory neurons and fibers from multiple spinal cord levels innervate the rabbit lumbar disc. Am J Phys Med Rahabil 2006;85: 865-71
29. Kuslich SD, Ulstrom CL, Michael CJ: The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am 1991;22: 181-7
30. Hashizume H, DeLeo JA, Colburn RW, et al: Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 2000;25:1206-17
31. Battie MC, Videman T, Gibbons LE, et al: 1995 Volvo Award in clinical sciences. Determinants of lumbar disc degeneration. A study relating lifetime exposures and magnetic resonance imaging findings in identical twins. Spine 1995;20:2601-12
32. Lotz JC, Colliou OK, Chin JR, et al: Compression-induced degeneration of the intervertebral disc: an in vivo mouse model and finite-element study. Spine 1998;23:2493-506
33. Lotz JC, Staples A, Walsh A, et al: Mechanobiology in intervertebral disc degeneration and regeneration. Conf Proc IEEE Eng Med Biol Soc 2004;7:5459
34. Pye SR, Reid DM, Adams JE, et al: Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration. Ann Rheum Dis 2007;66:426-7
35. Anderson DG, Tannoury C: Molecular pathogenic factors in symptomatic disc degeneration. Spine J 2005;5:260S-6S
36. Masuda K, Oegema TR Jr, An HS: Growth factors and treatment of intervertebral disc degeneration. Spine 2004;29:2757-69
37. Aguiar DJ, Johnson SL, Oegema TR: Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis. Exp Cell Res 1999;246:129-37
38. Kang JD, Georgescu HI, McIntyre-Larkin L, et al: Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996;21:271-7
39. Kang JD, Georgescu HI, McIntyre-Larkin L, et al: Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1995;20:2373-8
40. Gruber HE, Ingram JA, Hanley EN Jr: Immunolocalization of MMP-19 in the human intervertebral disc: implications for disc aging and degeneration. Biotech Histochem 2005;80:157-62
41. Zhang Y, An HS, Toofanfard M, et al: Low-dose interleukin-1 partially counteracts osteogenic protein-1-induced proteoglycan synthesis by adult bovine intervertebral disk cells. Am J Phys Med Rehabil 2005;84:322-9
42. Oegema TR Jr, Johnson SL, Aguiar DJ, et al: Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine 2000;25:2742-7
43. Anderson DG, Li X, Tannoury T, et al: A fibronectin fragment stimulates intervertebral disc degeneration in vivo. Spine 2003;28:2338-45
44. Henrotin Y, Kurz B, Aigner T: Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthr Cartil 2005;13:643-54
45. Thompson JP, Pearce RH, Schechter MT, et al: Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990;15:411-5
46. Griffith JF, Wang YX, Antonio GE, et al: Modified Pfirrmann grading system for lumbar intervertebral disc degeneration. Spine 2007;32:E708-12
47. Pfirrmann CW, Metzdorf A, Zanetti M, et al: Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine 2001;26:1873-8
48. Yoon ST: Molecular therapy of the intervertebral disc. Spine J 2005;5:280S-6S
49. Wallach CJ, Sobajima S, Watanabe Y, et al: Gene transfer of the catabolic inhibitor TIMP-I increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 2003;28:2331-7
50. Thompson JP, Oegema TR Jr, Bradford DS: Stimulation of mature canine intervertebral disc by growth factors. Spine 1991;16:253-60
51. Tim Yoon S, Su Kim K, Li J, et al: The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine 2003;28:1773-80
52. Zhang Y, An HS, Thonar EJ, et al: Comparative effects of adenovirus expressing bone morphogenetic proteins and Sox9 on extracellular matrix metabolism of bovine nu-cleus pulposus cells. Spine 2006;31:2173-9
53. Li X, Leo BM, Beck G, et al: Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine 2004;29:2229-34
54. Chujo T, An HS, Akeda K, et al: Effects of growth differentiation factor-5 on the intervertebral disc-in vitro bovine study and in vivo rabbit disc degeneration model study. Spine 2006;31:2909-17
55. Paul R, Haydon RC, Cheng H, et al: Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003;28:755-63
56. Yoon ST, Park JS, Kim KS, et al: ISSLS prize winner: LMP-I upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004;29:2603-11
57. Zhang Y, An HS, Song S, et al: Growth factor osteogenic protein-1: differing effects on cells from three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil 2004;83:515-21
58. An HS, Takegami K, Kamada H, et al: Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine 2005;30:25-31
59. Imai Y, Okuma M, An HS, et al: Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine 2007;32:1197-205
60. Miyamoto K, Masuda K, Kim JG, et al: Intradiscal injections of osteogenic protein-1 restore the viscoelastic properties of degenerated intervertebral discs. Spine J 2006;6:692-703
61. Shimer AL, Chadderdon RC, Gilbertson LG, et al: Gene therapy approaches for intervertebral disc degeneration. Spine 2004;29:2770-8
62. Nishida K, Kang JD, Gilbertson LG, et al: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 1999;24:2419-25
63. Raper SE, Chirmule N, Lee FS, et al: Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003;80:148-58
64. Bostanci A: Gene therapy. Blood test flags agent in death of Penn subject. Science 2002;295:604-5
65. DelloRusso C, Scott JM, Hartigan-O'Connor D, et al: Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Natl Acad Sci USA 2002;99:12979-84
66. Scott JM, Chamberlain JS: Gutted adenoviral vectors for gene transfer to muscle. Methods Mol Biol 2003;219:19-28
67. Lattermann C, Oxner WM, Xiao X, et al: The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits. Spine 2005;30:497-504
68. Sugiyama O, An DS, Kung SP, et al: Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 2005;11:390-8
69. Gruber HE, Hanley EN Jr: Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine 1998;23:751-7
70. Gruber HE, Johnson TL, Leslie K, et al: Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine 2002;27:1626-33
71. Ganey T, Libera J, Moos V, et al: Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc. Spine 2003;28:2609-20
72. Ganey TM, Meisel HJ: A potential role for cell-based therapeutics in the treatment of intervertebral disc herniation. Eur Spine J 2002;11(suppl 2):S206-14
73. Meisel HJ, Ganey T, Hutton WC, et al: Clinical experience in cell-based therapeutics: intervention and outcome. Eur Spine J 2006;3(15 Suppl):S397-405
74. Meisel HJ, Siodla V, Ganey T, et al: Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng 2007;24:5-21
75. Brittberg M, Lindahl A, Nilsson A, et al: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-95
76. Brittberg M, Nilsson A, Lindahl A, et al: Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin Orthop Relat Res 1996:270-83
77. Friedenstein AJ, Gorskaja JF, Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-74
78. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
79. Deans RJ, Moseley AB: Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875-84
80. Baksh D, Song L, Tuan RS: Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-16
81. Lin Z, Willers C, Xu J, et al: The chondrocyte: biology and clinical application. Tissue Eng 2006;12:1971-84
82. Steck E, Bertram H, Abel R, et al: Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells 2005;23:403-11
83. Song H, Kwon K, Lim S, et al: Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 2005;19:402-7
84. Zhang YG, Guo X, Xu P, et al: Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clin Orthop Relat Res 2005:219-26
85. Sakai D, Mochida J, Iwashina T, et al: Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 2005;30:2379-87
86. Xu Y, Balooch G, Chiou M, et al: Analysis of the material properties of early chondrogenic differentiated adipose-derived stromal cells (ASC) using an in vitro three-dimensional micromass culture system. Biochem Biophys Res Commun 2007;359:311-6
87. Gluckman E, Locatelli F: Umbilical cord blood transplants. Curr Opin Hematol 2000;7:353-7
88. Bieback K, Kern S, Kluter H, et al: Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625-34
89. Lee OK, Kuo TK, Chen WM, et al: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-75
90. Erices A, Conget P, Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-42
91. Gluckman E: Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000;28:1197-205
92. Kim SW, Man H. Chae GT: Successful stem cell therapy using umbilical cord blood-derived multi-potent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006;24:1620-6
93. Kang KS, Kim SW, Oh YH, et al: A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005;7:368-73
94. Leo BM, Li X, Balian G, et al: In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc. Spine 2004;29:838-44
95. Zhang Y, Li Z, Thonar EJ, et al: Transduced bovine articular chondrocytes affect the metabolism of cocultured nucleus pulposus cells in vitro: implications for chondrocyte transplantation into the intervertebral disc. Spine 2005;30:2601-7
96. Richardson SM, Mobasheri A, Freemont AJ, et al: Intervertebral disc biology, degeneration and novel tissue engineering and regenerative medicine therapies. Histol Histopathol 2007;22:1033-41
97. Wan Y, Feng G, Shen FH, et al: Biphasic scaffold for annulus fibrosus tissue regeneration. Biomaterials 2008;29:643-52
98. Nerurkar NL, Elliott DM, Mauck RL: Mechanics of oriented electrospun nanofibrous scaffolds for annulus fibrosus tissue engineering. J Orthop Res 2007;25:1018-28
99. Helen W, Merry CL, Blaker JJ, et al: Three-dimensional culture of annulus fibrosus cells within PDLLA/Bioglass composite foam scaffolds: assessment of cell attachment, proliferation and extracellular matrix production. Biomaterials 2007;28:2010-20
100. Halloran DO, Grad S, Stoddart M, et al: An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials 2008;29:438-47
101. Sebastine IM, Williams DJ: Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration. Conf Proc IEEE Eng Med Biol Soc 2007;1:6400-5
102. Richardson SM, Hughes N, Hunt JA, et al: Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials 2008;29:85-93
103. Cloyd JM, Malhotra NR, Weng L, et al: Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur Spine J 2007;16:1892-8
104. Le Visage C, Yang SH, Kadakia L, et al: Small intestinal submucosa as a potential bioscaffold for intervertebral disc regeneration. Spine 2006;31:2423-30
105. Wallach CJ, Kim JS, Sobajima S, et al: Safety assessment of intradiscal gene transfer: a pilot study. Spine J 2006;6:107-12